MediFind
Condition

Lung Cancer

Active Clinical Trials

Clinical Trial
Other
  • Status: Recruiting
  • Participants: 36
  • Start Date: January 1, 2021
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 58
  • Start Date: August 31, 2020
A Multi-Center, Phase I/II Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 160
  • Start Date: August 31, 2020
Phase 1 and Phase 2a, First-in-human Study of DRP-104, a Glutamine Antagonist, in Adult Patients With Advanced Solid Tumors